跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
劉 永慶
主治醫師
,
衛生福利部雙和醫院
https://orcid.org/0000-0002-7114-5552
電子郵件
yungching
tmu.edu
tw
h-index
7300
引文
43
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1983 …
2023
每年研究成果
概覽
指紋
網路
研究成果
(228)
類似的個人檔案
(6)
指紋
查看啟用 Yung-Ching Liu 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Antiinfective Agent
77%
Antimicrobial Resistance
70%
Tigecycline
49%
Infectious Agent
47%
Streptococcus Pneumoniae
47%
Penicillin Derivative
40%
Antibiotic Agent
38%
Meningitis
37%
Prevalence
36%
Enterobacteriaceae
35%
Disease
31%
Klebsiella pneumoniae
29%
Penicillinase
28%
Mycobacterium Tuberculosis Complex
28%
Moraxella catarrhalis
28%
Methicillin-Resistant Staphylococcus Aureus
27%
Pseudomonas aeruginosa
26%
Haemophilus influenzae
23%
Cephalosporin Derivative
23%
Bacterial Endocarditis
22%
Ciprofloxacin
22%
Carbapenem Derivative
21%
Gram Negative Bacterium
20%
Bacteremia
19%
Antibiotics
19%
Acinetobacter Baumannii
18%
Endocarditis
18%
Vancomycin
18%
Quinolone Derivative
18%
Cefepime
17%
Imipenem
17%
Minimum Inhibitory Concentration
17%
Ceftazidime
16%
Abdominal Infection
16%
Cotrimoxazole
16%
Extended Spectrum Beta Lactamase
16%
Escherichia coli
16%
Urinary Tract Infection
15%
Staphylococcus Aureus
15%
Pyogenic Liver Abscess
15%
Symptom
15%
Azithromycin
15%
Antibacterial Activity
14%
Ertapenem
14%
Legionella
14%
Molecular Epidemiology
14%
Eosinophilic Meningitis
14%
Agar Dilution
14%
Hospital Infection
13%
Immunology and Microbiology
Minimum Inhibitory Concentration
81%
Antimicrobial Resistance
70%
Streptococcus Pneumoniae
46%
Antibiotic Sensitivity
40%
Infectious Agent
36%
Mycobacterium Tuberculosis Complex
36%
Prevalence
33%
Penicillin
30%
Methicillin-Resistant Staphylococcus Aureus
29%
Moraxella catarrhalis
28%
Mycobacterium Tuberculosis
28%
Mycobacteria
25%
Pneumococcus
24%
Enterobacteriaceae
24%
Cerebrospinal Fluid
23%
Klebsiella pneumoniae
23%
Serotype
22%
Escherichia coli
22%
MIC90
22%
Meningitis
21%
Pseudomonas aeruginosa
17%
Haemophilus influenzae
17%
Human Immunodeficiency Virus
16%
Broth Dilution
15%
Influenza
15%
Human Immunodeficiency Virus 1
15%
Polymerase Chain Reaction
14%
Acinetobacter Baumannii
14%
Mycobacterium Avium Complex
14%
Gram-Negative Bacteria
13%
Vancomycin-Resistant Enterococcus
12%
Streptococcus pyogenes
12%
Enterococcus faecium
11%
Molecular Epidemiology
11%
Titer
11%
Disk Diffusion
10%
Liquid
10%
Vaccine Efficacy
10%
Seroprevalence
10%
Agar Dilution
9%
Autoantibodies
9%
Interferon Type I
9%
Vibrio vulnificus
9%
Mycobacteria Growth Indicator Tube
9%
Abscess
9%
Angiostrongylus cantonensis
9%
Extended Spectrum Beta Lactamase Producing Escherichia Coli
8%
Lower Respiratory Tract
8%
Sputum
8%
Endocarditis
8%
Medicine and Dentistry
Infection
99%
Antibiotic Resistance
43%
Antibiotics
42%
Disease
40%
Pathogen
36%
Liver Abscess
33%
Klebsiella pneumoniae
32%
Eosinophilic Meningitis
28%
Cerebrospinal Fluid
25%
Meningitis
24%
Gram-Negative Bacteria
22%
Symptom
21%
Bacteremia
21%
Pyogenic Liver Abscess
21%
Intensive Care Unit
21%
Angiostrongylus cantonensis
20%
Enterobacteriaceae
18%
Endocarditis
17%
Pseudomonas aeruginosa
17%
Infective Endocarditis
17%
Endophthalmitis
17%
Mycobacterium Tuberculosis
16%
Antiinfective Agent
15%
Abscess
15%
Differential Diagnosis
15%
In Vitro
15%
Prevalence
14%
Acquired Immune Deficiency Syndrome
14%
Mycobacterium Avium Complex
14%
Hospital Infection
13%
Pontiac Fever
13%
Headache
13%
Melioidosis
13%
Cohort Effect
13%
Ceftazidime
13%
Infection Control
12%
Lung Tuberculosis
12%
Penicillin Derivative
11%
Mycobacterium Tuberculosis Complex
11%
Acinetobacter Baumannii
11%
Legionella pneumophila
11%
Pneumocystis Pneumonia
11%
Community-Acquired Pneumonia
11%
Trimethoprim/Sulfamethoxazole
11%
Carbapenem Derivative
11%
Eosinophilia
11%
Emergency Department
11%
Opportunistic Infection
11%
Legionella
11%
Snail
11%
